Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.16
+0.15 (0.45%)
Nov 18, 2026, 1:05 PM EST - Market open
Harmony Biosciences Holdings Employees
Harmony Biosciences Holdings had 293 employees as of December 31, 2025. The number of employees increased by 25 or 9.33% compared to the previous year. That makes Harmony Biosciences Holdings the 24,021st largest employer in the world and 3,079th in the United States.
Employees
293
Change (1Y)
25
Growth (1Y)
9.33%
Revenue / Employee
$3,376,655
Profits / Employee
$609,560
Market Cap
1.95B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | 25 | 9.33% |
| Dec 31, 2024 | 268 | 22 | 8.94% |
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Beam Therapeutics | 557 |
| Replimune Group | 465 |
| Maravai LifeSciences Holdings | 410 |
| Vera Therapeutics | 362 |
| Biohaven | 274 |
| Immunome | 267 |
| Zenas BioPharma | 167 |
HRMY News
- 14 days ago - Harmony Biosciences Holdings Earnings Call Transcript: Q3 2026 - Transcripts
- 14 days ago - Harmony Biosciences Holdings Slides: Q3 2026 - Filings
- 14 days ago - Harmony Biosciences Holdings Earnings release: Q3 2026 - Filings
- 14 days ago - Harmony Biosciences Holdings Quarterly report: Q3 2026 - Filings
- 14 days ago - Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.03B - TheFly
- 14 days ago - Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile - GlobeNewsWire
- 20 days ago - Harmony Biosciences price target lowered to $49 from $51 at Mizuho - TheFly
- 27 days ago - Revisiting Former Stock Picks Marriott, Logitech, Harmony Biosciences - Barrons